The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4626842 5774031 I 4626842-5 20050210 20050317 20050331 EXP 2005BI006059 BIOGEN IDEC INC. F N 20050330

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4626842 1005846414 PS NATALIZUMAB 2 INTRAVENOUS 300 MG; QM; IV D D

Indications of drugs used

Event ID DRUG SEQ INDI PT
4626842 1005846414 MULTIPLE SCLEROSIS

Outcome of event

Event ID OUTC COD
4626842 HO

Reactions reported

Event ID PT
4626842 BLOOD PRESSURE DECREASED
4626842 HYPERSENSITIVITY

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4626842 CSM
4626842 SDY

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4626842 1005846414 20050101 20050210